Long-term outcome of stereotactic brachytherapy with temporary Iodine-125 seeds in patients with WHO grade II gliomas
Open Access
- 9 December 2020
- journal article
- research article
- Published by Springer Nature in Radiation Oncology
- Vol. 15 (1) , 1-10
Abstract
Background: This long-term retrospective analysis aimed to investigate the outcome and toxicity profile of stereotactic brachytherapy (SBT) in selected low-grade gliomas WHO grade II (LGGII) in a large patient series. Methods: This analysis comprised 106 consecutive patients who received SBT with temporary Iodine-125 seeds for histologically verified LGGII at the University of Munich between March 1997 and July 2011. Investigation included clinical characteristics, technical aspects of SBT, the application of other treatments, outcome analyses including malignization rates, and prognostic factors with special focus on molecular biomarkers. Results: For the entire study population, the 5- and 10-years overall survival (OS) rates were 79% and 62%, respectively, with a median follow-up of 115.9 months. No prognostic factors could be identified. Interstitial radiotherapy was applied in 51 cases as first-line treatment with a median number of two seeds (range 1–5), and a median total implanted activity of 21.8 mCi (range 4.2–43.4). The reference dose average was 54.0 Gy. Five- and ten-years OS and progression-free survival rates after SBT were 72% and 43%, and 40% and 23%, respectively, with a median follow-up of 86.7 months. The procedure-related mortality rate was zero, although an overall complication rate of 16% was registered. Patients with complications had a significantly larger tumor volume (p = 0.029). Conclusion: SBT is a minimally invasive treatment modality with a favorable outcome and toxicity profile. It is both an alternative primary treatment method as well as an adjunct to open tumor resection in selected low-grade gliomas.Keywords
Funding Information
- Projekt DEAL
This publication has 38 references indexed in Scilit:
- Iodine-125 brachytherapy for brain tumours - a reviewRadiation Oncology, 2012
- Stereotactic brachytherapy of low-grade cerebral glioma after tumor resectionNeuro-Oncology, 2011
- Functional mapping–guided resection of low-grade gliomas in eloquent areas of the brain: improvement of long-term survivalJournal of Neurosurgery, 2011
- Guidelines on management of low‐grade gliomas: report of an EFNS–EANO* Task ForceEuropean Journal of Neurology, 2010
- Interstitial125I radiosurgery of supratentorial de novo WHO Grade 2 astrocytoma and oligoastrocytoma in adultsCancer, 2006
- Interstitial radiosurgery of low-grade gliomasJournal of Neurosurgery, 1995
- Comparison of Stereotactic Radiosurgery and Brachytherapy in the Treatment of Recurrent Glioblastoma MultiformeNeurosurgery, 1995
- Comparison of Stereotactic Radiosurgery and Brachytherapy in the Treatment of Recurrent Glioblastoma MultiformeNeurosurgery, 1995
- Supratentorial low-grade astrocytoma. Correlation of computed tomography findings with effect of radiation therapy and prognostic variablesCancer, 1993
- Intracranial arterial occlusion associated with high-activity iodine-125 brachytherapy for glioblastomaJournal of Neuro-Oncology, 1993